Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Intangibles (2018 - 2025)

Historic Intangibles for Cytosorbents (CTSO) over the last 8 years, with Q3 2025 value amounting to $3.6 million.

  • Cytosorbents' Intangibles changed N/A to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year change of. This contributed to the annual value of $3.7 million for FY2024, which is 405.86% down from last year.
  • Per Cytosorbents' latest filing, its Intangibles stood at $3.6 million for Q3 2025.
  • Cytosorbents' Intangibles' 5-year high stood at $4.7 million during Q4 2021, with a 5-year trough of $3.6 million in Q3 2025.
  • In the last 5 years, Cytosorbents' Intangibles had a median value of $3.7 million in 2024 and averaged $4.0 million.
  • In the last 5 years, Cytosorbents' Intangibles surged by 1135.82% in 2021 and then plummeted by 1102.33% in 2023.
  • Quarter analysis of 5 years shows Cytosorbents' Intangibles stood at $4.7 million in 2021, then fell by 6.62% to $4.4 million in 2022, then fell by 11.02% to $3.9 million in 2023, then dropped by 4.06% to $3.7 million in 2024, then decreased by 4.16% to $3.6 million in 2025.
  • Its Intangibles stands at $3.6 million for Q3 2025, versus $3.7 million for Q2 2025 and $3.7 million for Q1 2025.